Sinil Kim

9.9k citations
90 papers · 5.7k · 4 hit papers · h-index 30

Impact in

Papers in

Sinil Kim

89 papers receiving 5.5k citations

Sinil Kim's Hit Papers

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors 2016 · 700 citations
7000+6+12Years since publication200400600

Peers

Sinil Kim
Comparison fields: 5 of 135
  • Cancer Research 1.4k
  • Pulmonary and Respiratory Medicine 2.0k
  • Oncology 1.5k
  • Molecular Biology 2.3k
  • Endocrinology, Diabetes and Metabolism 462
Replace Dominic T. Moore with:
Dominic T. Moore United States
Miguel A. Villalona‐Calero United States
Yasuhide Yamada Japan
Madappa N. Kundranda United States
Andries M. Bergman Netherlands
David S. Schrump United States
Dick J. Richel Netherlands
William G. Cance United States
Hing Y. Leung United Kingdom
Konstantinos N. Syrigos Greece
Sinil Kim relative to Dominic T. Moore United States Dominic T. Moore's profile →
Citations per field
00.5×2.9×
Dominic T. Moore · 1×
Citations per year

Countries citing papers authored by Sinil Kim

Since Specialization
Citations

This map shows the geographic impact of Sinil Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinil Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinil Kim more than expected).

Fields of papers citing papers by Sinil Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sinil Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinil Kim. The network helps show where Sinil Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Sinil Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sinil Kim Line = papers co-authored together Sinil Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Hit paper breakdown →
2016700
2
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Hit paper breakdown →
2013544
3
Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
Hit paper breakdown →
2008495
4 2007357
5 2011323
6
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hit paper breakdown →
2013321
7 2009271
8 2008204
9 2013184
10 2011151
11 1983149
12 2009147
13 2013117
14 201193
15 201486
16 201185
17 199384
18 199474
19 198174
20
Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
198771

About Sinil Kim

Sinil Kim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology, Oncology and Plant Science, having authored 90 papers that have together received 5.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Fungal Biology and Applications (12 papers), Mycorrhizal Fungi and Plant Interactions (7 papers), Fungal and yeast genetics research (7 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Cancer Genomics and Diagnostics (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (2.0k citations), Oncology (1.5k citations), Molecular Biology (2.3k citations) and Endocrinology, Diabetes and Metabolism (462 citations). Sinil Kim has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Brian I. Rini, Brad Rosbrook, Paul Bycott, Katherine Liau, Jamal Tarazi, Peter C. Trask, Robert J. Motzer, Connie Chen, Andrew Brenner and David S. Hong. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Lancet Oncology, Gynecologic Oncology and Scientia Horticulturae.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact